Donor-specific antibodies and liver transplantation
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 77 (11) , 1063-1070
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantationLiver Transplantation, 2013
- The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver TransplantationAmerican Journal of Transplantation, 2011
- Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodiesLiver Transplantation, 2010
- Prevalence of anti-HLA antibodies after liver transplantationTransplant International, 2009
- New Insights into Mechanisms of Spontaneous Liver Transplant Tolerance: The Role of Foxp3-Expressing CD25+CD4+ Regulatory T CellsAmerican Journal of Transplantation, 2008
- The importance of CD25+CD4+ regulatory T cells in mouse hepatic allograft toleranceLiver Transplantation, 2006
- Detection of Anti-MICA Antibodies in Patients Awaiting Kidney Transplantation, during the Post-transplant Course, and in Eluates from Rejected Kidney Allografts by Luminex Flow CytometryHuman Immunology, 2006
- Intracellular Expression of MICA in Activated CD4 T Lymphocytes and Protection from NK Cell-Mediated MICA-Dependent CytotoxicityHuman Immunology, 2006
- CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplantHuman Immunology, 2000
- HLA-DRB1 and -DQB1 Polymorphism in Liver Recipients: Relationship Between HLA-DQB10302 Allele Frequency and Acute RejectionHuman Immunology, 1997